Vaccines
Vaccine developers and manufacturers need robust CMC documentation, cold-chain data integrity, and a regulatory intelligence layer that keeps up with WHO PQ, EMA and FDA. Cybroscape supports the full lifecycle.
Vaccine manufacturing combines biologics process complexity with high public scrutiny and, frequently, compressed timelines. The validation burden concentrates on cold chain integrity, the systems holding batch genealogy, and the data integrity controls across a supply chain where a single temperature excursion has to be traceable to the doses it affected.
Identify The Roadblocks Slowing Your Growth
These challenges compound: cycles slow, scaling gets harder, and inspection posture drifts.
Regulations We Cover
Every vaccines engagement is mapped to the regulations your inspectors will use.
GMP
- WHO PQ
- FDA CBER
- EU GMP Annex 11
- ICH Q5 / Q6
- 01DevelopmentELNLIMSDevelopment data that can support a filing
- 02ManufacturingMESSCADAData historianProcess control for a biologic
- 03QC and lot releaseLIMSCDSLot release testing and its evidence
- 04Cold chainTemperature monitoringWMSAn unbroken cold chain
- 05Safety follow-upSafety databaseAdverse events followed up and reported
Services & Products For Vaccines
- CSV
- Data Integrity
- Regulatory Intelligence
- CSR Authoring
- GxP CopilotAI-native, CSA-first computer system validation for Life Sciences.
- TraceDraftSource-traceable drafting and analysis of clinical and regulatory documents.
- Cybroscape eQMSAn agentic quality management system for pharma, biotech and medical devices.
- Study IntelligenceAgentic intelligence across your studies — samples, biomarker data, operations and vendors in one place.
Cold-Chain Data Integrity: The Validation Challenge in Temperature-Sensitive Biologics
Vaccine cold-chain data integrity is among the most technically demanding data governance challenges in pharmaceutical manufacturing. Temperature excursions during transport and storage are both a product quality event and a data integrity event: the temperature monitoring records are primary GMP evidence that the cold chain was maintained throughout the distribution journey. Where those records are maintained by multiple parties — the contract cold-chain logistics provider, the destination warehouse, and the final site — each party's data management practices contribute to or undermine the overall data integrity posture.
The specific data integrity requirements for vaccine cold-chain monitoring include: continuous temperature monitoring throughout the cold chain with calibrated sensors; audit-trail-protected electronic records that cannot be modified after the fact; a defined excursion alert and investigation process that documents the response to every temperature deviation; and data that is traceable back to the calibration records of the monitoring equipment used. Our vaccine practice validates the cold-chain monitoring systems — from datalogger firmware through the data management application — against ALCOA+ and WHO PQ requirements.
- 14:32Signed: Approved for releaseQA Manager
- 11:05Changed risk of URS-015Validation lead · Supplier test evidence acceptedMedium → Low
- 10:48Edited expected result, OQ-07Validation lead · Lockout after 5 attempts, per URSv3 → v4
- 09:12Recorded result, OQ-07Tester · Evidence attachedPassed
WHO Prequalification and CBER: Parallel Regulatory Compliance
Vaccine manufacturers seeking to supply global health programmes must navigate WHO Prequalification (WHO PQ) requirements in parallel with their domestic regulatory obligations (CBER for FDA, EMA for European authorisation, or CDSCO for India). WHO PQ has its own technical documentation requirements, site inspection process, and quality management expectations — and while WHO PQ broadly aligns with ICH and GMP standards, there are specific WHO requirements around batch release testing, potency assay design, and cold-chain distribution that differ from FDA and EMA expectations.
TraceDraft's regulatory intelligence layer tracks WHO PQ technical requirements and generates documentation structured to WHO PQ templates alongside the ICH-format documentation required for FDA and EMA submissions. For vaccine manufacturers pursuing simultaneous multi-market approvals, this reduces the documentation duplication that arises when WHO PQ and ICH documentation are managed as separate parallel workstreams. The CMC documentation structure for a vaccine submission — from the drug substance manufacturing description through the drug product specifications and stability data — can be generated in a single TraceDraft workflow with market-specific outputs.
mRNA Vaccine Platform Validation: New Platform, Same ALCOA+ Standard
mRNA vaccine platforms present validation teams with a novel challenge: the manufacturing process is substantially different from traditional vaccine manufacturing, with novel lipid nanoparticle formulation steps, temperature-sensitive intermediate products, and analytical methods that are less mature than those for established vaccine platforms. The regulatory expectations — GMP compliance, validated manufacturing processes, qualified analytical methods — are unchanged, but the validation evidence base is thinner for a new platform than for an established one.
ICH Q5 and Q6 provide the quality standard framework for biological products including mRNA vaccines. ICH Q5E (comparability) is particularly relevant as mRNA vaccine manufacturers optimise their manufacturing processes: any manufacturing change for a licensed product must be assessed through the ICH Q5E comparability framework, with analytical comparability data demonstrating that the product quality is maintained. Cybroscape's vaccine practice helps manufacturers establish the analytical method validation package and the manufacturing process validation documentation that supports both initial licensure and the ongoing comparability obligations of the product lifecycle.
Explore More For Regulated Life Sciences
Vaccines validation without the backlog.
Bring one system. A vaccines validation lead shows you the package it produces.
- We reply within one business day
- We run your URS live on the call
- You get a clear plan for your system